-

SHAREHOLDER ALERT: Robbins LLP Is Investigating ATI Physical Therapy, Inc. (ATIP) f/k/a Fortress Value Acquisition Corp. II (FVAC) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating ATI Physical Therapy, Inc. (NYSE: ATIP) to determine whether certain ATI officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. ATI is an outpatient physical therapy company that owns and operates nearly 900 clinics across 25 states.

If you would like more information about ATI Physical Therapy, Inc.'s misconduct, click here.

ATI Physical Therapy, Inc. (ATIP) is Accused of Making Misleading Statements Regarding its Business, Operations, and Prospects

A class action was filed on behalf of purchasers of ATI securities between April 1, 2021 and July 23, 2021, and purchasers who held FVAC Class A common stock as of May 24, 2021 and were eligible to vote at FVAC's June 15, 2021 special meeting. FVAC was a special purpose acquisition company that went public in August 2020. On June 17, 2021, ATI became public via a business combination with FVAC.

According to the complaint, during the relevant period, the Company stated it was "focused on accelerating hiring to serve outsized demand," noting it was the "Employer of Choice for PT Clinicians" and touted its staffing strategy, claiming that it would achieve "significant labor savings through more productive staffing model."

On July 26, 2021, ATI reported its financial results for second quarter 2021, the period in which the business combination was complete. ATI reported that “the acceleration of attrition among [its] therapists in the second quarter and continuing into the third quarter, combined with the intensifying competition for clinicians in the labor market, prevented us from being able to meet the demand we have and increased our labor costs.” Though ATI was implementing certain remedial actions, the Company reduced its fiscal 2021 forecast due to the foregoing factors. On this news, the Company's share price fell $3.62, or 43%, to close at $4.72 per share on July 26, 2021, and declined an additional 19% the next trading session. The stock has not recovered and now trades below $3.00.

ATI Physical Therapy, Inc. (ATIP) shareholders have legal options. If you own shares of ATI Physical Therapy, Inc. contact us to learn more about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against ATI Physical Therapy, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:ATIP

Release Summary
ATI Physical Therapy, Inc. (ATIP) is Accused of Making Misleading Statements Regarding its Business, Operations, and Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Robbins LLP Informs Investors of the Securities Class Action Against Oracle Corporation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware. For more information,...

Investor Notice: Robbins LLP Informs Investors of the Smart Digital Group Limited Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Smart Digital Group Limited (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025. Smart Digital, together with its subsidiaries, provides internet media, business planning and consulting, event planning and execution, and software customization and marketing services in Mainland China and Macau. For more information, submit a fo...
Back to Newsroom